Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome

Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Tveit Haavind M, Innella G, Turchetti D, Aretz S, Spier I, Tischkowitz M, Jahn A, Links TP, Olderode-Berends MJW, Blatnik A, Leter EM, Evans DG, Woodward ER, Steinke-Lange V, Anastasiadou VC, Colas C, Villy M, Benusiglio PR, Gerasimenko A, Barili V, Branchaud M, Houdayer C, Tesi B, Yazicioglu MO, Van der Post RS, Schuurs-Hoeijmakers JHM, PTEN Study Group, Vos JR.

J Natl Cancer Inst. 2022. https://doi.org/10.1093/jnci/djac188

Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort

Hendricks LAJ, Hoogerbrugge N, Venselaar H, Aretz S, Spier I, Legius E, Brems H, de Putter R, Claes KBM, Evans DG, Woodward ER, Genuardi M, Brugnoletti F, van Ierland Y, Dijke K, Tham E, Tesi B, Schuurs-Hoeijmakers JHM, Branchaud M, Salvador H, Jahn A, Schnaiter S, Anastasiadou VC, Brunet J, Oliveira C, Roht L, Blatnik A, Irmejs A, PTEN Study Group, Mensenkamp AR, Vos JR.

European Journal of Medical Genetics (2022). https://doi.org/10.1016/j.ejmg.2022.104632

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.

Alma Hoxhaj A, Drissen MMCM, Vos JR, Bult P, Mann RM, Hoogerbrugge N.

Cancer 2022. https://doi.org/10.1002/cncr.34326

Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM, Vos JR, van der Biessen-van Beek DTJ, van der Post RS, Nagtegaal ID, van Kouwen MCA, Bisseling TM, Hoogerbrugge N. 

Cancers. 2022;14(16):4005. PMID: 36010998